Senior Investigator, Lady Davis Institute
Associate Professor, Departments of Neurology and Neurosurgery, McGill University
Dr. Christel Renoux is a neurologist and epidemiologist, Associate Professor in the Department of Neurology at McGill University, associate member in the Department of Epidemiology, Biostatistics and Occupational Health, and Senior Investigator at the Centre for Clinical Epidemiology at the Jewish General Hospital-Lady Davis Institute for Medical Research. Following her MSc in Epidemiology from McGill, she obtained a PhD in Neurosciences (neuroepidemiology) from Lyon 1 University in France. She completed a postdoctoral fellowship in pharmacoepidemiology at the Department of Epidemiology, Biostatistics and Occupational Health, McGill University. She was appointed Assistant Professor in 2012.
Dr. Renoux holds a Chercheur-Boursier junior 2 Award from the Fonds de recherche du Québec – Santé.
Major Research Activities
Dr. Renoux’s research program focuses on neuroepidemiology and pharmacoepidemiology. Using various large health databases, she evaluates the safety and effectiveness of medications, particularly related to neurological and psychiatric medications and outcomes, while applying advanced epidemiological methods. She also studies the epidemiology of cerebrovascular diseases in terms of risk factors, prevention and treatment. Her research has been funded by various organizations such as the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation, and Parkinson Canada.
Montastruc F, Nie R, Loo S, Rej S, Dell'Aniello S, Micallef J, Suissa S, Renoux C. Association of Aripiprazole with the Risk for Psychiatric Hospitalization, Self-harm, or Suicide. JAMA Psychiatry. 2019 Apr 1;76(4):409-417.
Loo S, Azoulay L, Nie R, Dell’Aniello S, Hoi Yun Yu O, Renoux C. Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study. Am J Med 2019. Sep;132(9):1069-1077.
Douros A, Azoulay L, Yin H, Suissa S, Renoux C. Non-vitamin K antagonist oral anticoagulants and the risk of serious liver injury: a cohort study. J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113.
Renoux C, Vahey S, Dell’Aniello S, Boivin J-F. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage. JAMA Neurology. 2017 Feb 1;74(2):173-180.